Accès à distance ? S'identifier sur le proxy UCLouvain
The efficacy and safety of recombinant human activated protein C for the treatment of patients with severe sepsis (vol 28, pg 48, 2000)
Primary tabs
| Document type | Article de périodique (Journal article) |
|---|---|
| Publication date | 2001 |
| Language | Anglais |
| Journal information | "Critical Care Medicine" - Vol. 29, no. 2, p. 469-469 (2001) |
| Peer reviewed | yes |
| Publisher | Lippincott Williams & Wilkins (Philadelphia) |
| issn | 0090-3493 |
| e-issn | 1530-0293 |
| Publication status | Publié |
| Affiliation | UCL |
| Links |
| Bibliographic reference | Bernard, GR ; LaRosa, SP ; Laterre, Pierre-François ; Ely, EW ; Dhainaut, JF ; et. al. The efficacy and safety of recombinant human activated protein C for the treatment of patients with severe sepsis (vol 28, pg 48, 2000). In: Critical Care Medicine, Vol. 29, no. 2, p. 469-469 (2001) |
|---|---|
| Permanent URL | http://hdl.handle.net/2078.1/42894 |